p190 BCR-ABL rearrangement in chronic myeloid leukemia and acute lymphoblastic leukemia

Cancer Genetics and Cytogenetics

Volumn 113, Issue 1, 1999, Pages 100-102

  Lemes, Angelina ^a   Casares, M Teresa Gómez ^a   De La Iglesia, Silvia ^a   Matutes, Estella ^b   Molero, M Teresa ^a  

^a Ntra Sra del Pino Hospital   (Spain)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; HYDROXYUREA; INTERFERON; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW; CASE REPORT; CHROMOSOME REARRANGEMENT; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTOSIS; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ADULT; BONE MARROW; DISEASE PROGRESSION; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0032839821     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00014-X     Document Type: Article

References (11)

1. Costello R.T., Gabert J., Brunel V., Sainty D., Arnoulet C., Mozziconacci M.J., Camerlo J., Perret C., Gastaut J.A., Bouabdallah R., Lafage-Pochitaloff M. Minor breakpoint cluster region (m-BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset. a case report Br J Haematol. 91:1995;428-430.
2. Kirk J.A., Radich J., Edmands S., Lee A., VanDevanter D.R., Reems J.A., Bryant E.M. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia. Am J Hematol. 52:1996;129-134.
3. Yamaguchi H., Inokuchi K., Shinohara T., Dan K. Extramedullary presentation of chronic myelogenous leukemia with p190 BCR/ABL transcripts. Cancer Genet Cytogenet. 102:1998;74-77.
4. Shepherd PCA, Ganesan TS, Galton DAG (1987): Baillière's Clin Haematol 1:53-57.
5. Melo J.V., Myint H., Galton D.A.G., Goldman J.M. P190 BCR-ABL chronic myeloid leukaemia. the missing link with chronic myelomonocytic leukemia? Leukemia. 8:1994;208-211.
6. Ribera JM, Fontanilla M, Oriol A, Feliu E, Maldonado J, Hdez-Rivas J, Marín J, Zuazu J, Rivas C, Alcalá J, Brunet S, Rafecas FJ, Carnero J, Besalduch J, Gardella S, Alvarez J, García-Conde J, Fdez-Calvo F, Martinez J, Moro MJ, Casanova R, Varela J, San Miguel JF, Ortega JJ, PETHEMA (Associación Española de Hematología) (1996): LAL del adulto: resultados del protocolo PETHEMA LAL-89 [Abstract]. Sangre 14:94.
7. Berger R. Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia. Leuk Lymphoma. 11:1993;235-237.
8. Dhingra K., Moshe T., Kantarjian H., Ku S., Rothberg J., Gutterman J.U., Kurzrock Appeareance of acute leukemia associated P190 BCR-ABL in chronic myelogenous leukemia may correlate with disease progression. Leukemia. 5:1991;191-195.
9. Kelliger M., Knott A., McLaughlin J., Witte O.N., Rosenberg N. Differences in oncogenic potency but not target cell specifity distinguish the two forms of the BCR/ABL oncogene. Mol Cell Biol. 11:1991;4710-4716.
10. Saglio G., Pane F., Gottardi E., Frigeri F., Buonaiuto M.R., Guerrasio A., de Micheli D., Parziale A., Fornaci M.N., Martinelli G., Salvatore F. Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosis. Blood. 87:1996;1075-1080.
11. van Rhee F., Hochhaus A., Lin F., Melo J., Goldman J., Cross N.C.P. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias. Blood. 87:1996;5213-5217.